This blend combines CJC-1295 (without a DAC) and Ipamorelin (IPA), two peptides that have been researched for their roles in signaling the growth hormone axis and related endocrine pathways. Preclinical research studies explore their receptor-mediated effects, pulsatile signaling dynamics, and downstream biomarkers. This product is intended for research use only.
Current COA—>CJC/IPA 10mg
Fast pricing. No commitment. Instant response.